Predict your next investment

Asset/Investment Management
bcif.com.au

See what CB Insights has to offer

Investments

1

About Bio Capital Impact Fund

Bio Capital Impact Fund is a new evergreen open-ended global fund investing in health, agricultural biotechnology, and industrial biotechnology companies. Its evergreen, open-ended fund enables continuous and flexible deal flow. It has no sunset date or cap on the value of the fund.

Bio Capital Impact Fund Headquarter Location

Melbourne, Victoria,

Australia

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Latest Bio Capital Impact Fund News

NovellusDx Completes $6M Equity Financing

Apr 30, 2018

NovellusDx , a Jerusalem, Israel-based functional genomics company, completed a $6m equity financing. Backers in the round, which adds to the nearly $17m already raised, included Helsinn Investment Fund S.A. SICAR, part of Helsinn Group, a cancer care company, Bio Capital Impact Fund, and Windham Venture Partners. The company intends to use the funds to accelerate the execution of its strategy, move into commercialization, support continuing development and enhancement of its technology using the R&D team in Jerusalem. Led by Haim Gil-Ad, CEO, NovellusDx provides functional information about mutations and their responses to drugs, which enables oncologists to treat patients with precision therapies and bio-pharmaceutical companies to develop drugs more effectively. The approach is to monitor the functional effects of mutations and observe the effects of drugs, drug combinations and drug candidates on the activity level caused by the mutations. FinSMEs

Bio Capital Impact Fund Investments

1 Investments

Bio Capital Impact Fund has made 1 investments. Their latest investment was in Novellus as part of their Series B - III on April 4, 2018.

CBI Logo

Bio Capital Impact Fund Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

4/30/2018

Series B - III

Novellus

$6M

Yes

6

Date

4/30/2018

Round

Series B - III

Company

Novellus

Amount

$6M

New?

Yes

Co-Investors

Sources

6

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.